Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial

Correction to: Nature Medicine https://doi.org/10.1038/s41591-025-03640-8, published online 4 April 2025.

In the version of this article initially published, there were typographical errors in the units listed in the Methods “Manufacturing of AFM13-NK cells from CB” section, where in the text now reading “The NK cells were enriched … followed by preactivation for 16 h with 10 ng ml IL-12 (Miltenyi Biotec), 50 ng ml⁻¹ IL-15 (R&D Systems) and 50 ng ml⁻¹ IL-18 (R&D Systems),” “µg” appeared instead of “ng” in three places. The errors have been corrected in the HTML and PDF versions of the article.